December 23, 2015
Eisai Pharmaceuticals has partnered with The Chase Group to identify oncology talent for two critical positions within their Clinical Development organization. We are pleased to announce that we are recruiting for an experienced industry physician to lead the Novel Oncology Compounds Group and a Study Director to lead and provide medical oversight of global Phase III pivotal trial(s) within the Oncology Portfolio. For more information about these opportunities or to learn about The Chase Group’s strength in securing oncology talent, please contact chase@chasegroup.com
